(Q62111048)

English

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

clinical trial

Statements

A Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Keratinocyte Growth Factor (rHuKGF) in Patients With Hematologic Malignancies Undergoing Total Body Irradiation (TBI) and High-Dose Chemotherapy With Autologous Peripheral Blood Progenitor Cell (PBPC) Transplantation (English)
0 references
0 references
0 references
0 references
0 references
January 2000
0 references
0 references
0 references
0 references
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit